Correlation between denial of illness and executive function following stroke: a pilot study.
Executive function and denial of illness were examined among 24 patients who received double-blind antidepressant treatment following stroke. Between end-of-treatment at 3 months and follow-up at 2 years, significant correlation was found between improvement in executive function and decrease in denial of illness.
Narushima
Kenji
K
Department of Psychiatry, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, 200 Hawkins Dr., 2887 JPP, IA City, IA 52246, USA.
Moser
David J
DJ
Robinson
Robert G
RG
D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003717:Denial, Psychological; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010865:Pilot Projects; D011340:Problem Solving / Q000187:drug effects / Q000502:physiology; D012189:Retrospective Studies; D013223:Statistics as Topic; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology*
D000928:Antidepressive Agents